RxNorm Semantic Concepts Index - 768
What is RxNorm?
RxNorm is a system developed and maintained by the National Library of Medicine (NLM). RxNorm is a normalized naming system for generic and branded drugs. RxNorm is also a tool that supports interoperability between different drug terminologies and other naming systems.
The following table is a complete listing of RxNorm concepts whose unique RxCUI identifier starts with "768".
| Concept ID (RxCUI) | Name | Term Type | Term Type Description | Is Prescribable? |
|---|---|---|---|---|
| Concept ID (RxCUI): 768 | Synflex | Brand Name (BN) | A proprietary name for a family of products containing a specific active ingredient. | NO |
| Concept ID (RxCUI): 768195 | Flumazenil (18-F) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768195 | Flumazenil (18-F) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768195 | Flumazenil (18-F) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768195 | Flumazenil (18-F) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768320 | Dipeptidase | Synonym (SY) | Synonym of another TTY, given for clarity. | NO |
| Concept ID (RxCUI): 768427 | Product containing sodium iodide (124-I) (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768427 | Product containing sodium iodide (124-I) (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768427 | Product containing sodium iodide (124-I) (medicinal product) | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768427 | Product containing sodium iodide (124-I) (medicinal product) | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768688 | Cryoprecipitate | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768688 | Cryoprecipitate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768688 | Cryoprecipitate | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Synonym (SY) | Synonym of another TTY, given for clarity. | YES |
| Concept ID (RxCUI): 7688 | Orciprenaline-containing product | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 768822 | Carbon (11-C) mespiperone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768822 | Carbon (11-C) mespiperone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768822 | Carbon (11-C) mespiperone | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768822 | Carbon (11-C) mespiperone | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 76887 | quinagolide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 76887 | quinagolide | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | NO |
| Concept ID (RxCUI): 76887 | quinagolide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 76887 | quinagolide | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 76887 | quinagolide | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 76895 | Reteplase | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 76895 | Reteplase | Ingredient (IN) | A compound or moiety that gives the drug its distinctive clinical properties. Ingredients generally use the United States Adopted Name (USAN). | YES |
| Concept ID (RxCUI): 76895 | Reteplase | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 76895 | Reteplase | Full form of descriptor (FN) | YES | |
| Concept ID (RxCUI): 76895 | Reteplase | Designated preferred name (PT) | YES | |
| Concept ID (RxCUI): 768967 | Carbon (11-C) flumazenil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768967 | Carbon (11-C) flumazenil | Full form of descriptor (FN) | NO | |
| Concept ID (RxCUI): 768967 | Carbon (11-C) flumazenil | Designated preferred name (PT) | NO | |
| Concept ID (RxCUI): 768967 | Carbon (11-C) flumazenil | Full form of descriptor (FN) | NO |